Summary
Radiochromium uptake and release by isolated rat hepatocytes in suspension was monitored under continuous-labeling conditions. Cell protein remained unchanged during the absorption phase, whereas the release of51Cr correlated well with the loss of cell viability and release of cytoplasmic protein. The results suggest that under equilibrium conditions,51Cr release represents an efflux of label from damaged or dying preparations and not an elution of radioisotope from intact cells.
Similar content being viewed by others
References
Phillips, H. J. 1973. Dye exclusion tests for cell viability. In: P. F. Kruse, Jr., and M. K. Patterson (Eds.),Tissue Culture: Methods and Applications. Academic Press, New York, pp. 406–408.
Engelfriet, C. P., and A. Britten. 1966. Cytotoxic antibodies against leukocytes. Vox Sang. 11: 334–344.
Walford, R. L., R. Gallagher, and G. M. Troup. 1965. Human lymphocyte typing with isologous antisera; technical considerations and a preliminary study of the cytotoxic reaction system. Transplantation 3: 387–401.
Öbrink, B., M. S. Kuhlenschmidt, and S. Roseman. 1977. Adhesive specificity of juvenile rat and chicken liver cells and membranes. Proc. Nat. Acad. Sci. U.S.A. 74: 1077–1081.
Rao, K. V., J. V. George, and D. E. S. Truman. 1973. On the physico-chemical basis of cell adhesion. Curr. Sci. 42: 340–343.
Jeejeebhoy, K. N., J. Ho, G. R. Greenberg, M. J. Phillips, A. Bruce-Robertson, and U. Sodtke. 1975. Albumin, fibrinogen and transferrin synthesis in isolated rat hepatocyte suspensions. Biochem. J. 146: 141–155.
Lowry, O. H., N. J. Rosebrough, A. L. Farr, and R. J. Randall. 1951. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193: 265–275.
Gibaldi, M., and D. Perrier. 1975.Pharmacokinetics. Marcel Dekker, Inc., New York, pp. 1–43.
Barr, R. D., W. Dougherty, and S. Perry. 1976. A reappraisal of cellular labeling with radiochromium salts. J. Lab. Clin. Med. 88: 1032–1040.
Miller, L. L., and W. F. Bale. 1954. Synthesis of all plasma protein fractions except gamma globulins by the liver. J. Exp. Med. 99: 125–132.
Miller, L. L., C. G. Bly, M. L. Watson, and W. F. Bale. 1951. The dominant role of the liver in plasma protein synthesis. J. Exp. Med. 94: 431–453.
Crane, L. J., and D. L. Miller. 1977. Plasma protein synthesis by isolated rat hepatocytes. J. Cell Biol. 72: 11–25.
Weigand, K., and I. Otto. 1974. Secretion of serum albumin by enzymatically isolated rat liver cells. FEBS Lett. 46: 127–129.
Crane, L. J., and D. L. Miller. 1974. Synthesis and secretion of fibrinogen and albumin by isolated rat hepatocytes. Biochem. Biophys. Res. Commun. 60: 1269–1277.
East, A. G., L. N. Louis, and R. Hoffenberg. 1973. Albumin synthesis by isolated rat liver cells. Exp. Cell Res. 76: 41–46.
Weigand, K., M. Müller, J. Urban, and G. Schreiber. 1971. Intact endoplasmic reticulum and albumin synthesis in rat liver cell suspensions. Exp. Cell Res. 67: 27–32.
Seglen, P. O., and A. Reith. 1977. Ammonia inhibits protein secretion in isolated rat hepatocytes. Biochim. Biophys. Acta 496: 29–35.
Rotermund, H.-M., G. Schreiber, H. Maeno, U. Weinssen, and K. Weigand. 1970. The ratio of albumin synthesis to total protein synthesis in normal rat liver, in host liver, and in Morris Hepatoma 9121. Cancer Res. 30: 2139–2146.
Schreiber, G., H.-M. Rotermund, H. Maeno, K. Weigand, and R. Lesch. 1969. The proportion of the incorporation of leucine into albumin to that into total protein in rat liver and Hepatoma Morris 5123 TC. Eur. J. Biochem. 10: 355–361.
Steele, G., Jr., H. O. Sjögren, O. Lannerstad, and I. Stadenberg. 1975. A long-term51chromium assay forin vitro cell-mediated tumour immunity. Correlation with simultaneously performed microplate assays. Int. J. Cancer 16: 682–693.
Dunkley, M., R. G. Miller, and K. Shortman. 1974. A modified51Cr release assay for cytotoxic lymphocytes. J. Immunol. Methods 6: 39–51.
Keller, R. 1973. Cytostatic elimination of syngeneic rat tumour cellsin vitro by non-specifically activated macrophages. J. Exp. Med. 138: 625–644.
Canty, T. G., and J. R. Wunderlich. 1970. Quantitativein vitro assay of cytotoxic cellular immunity. J. Nat. Cancer Inst. 45: 761–772.
McMillan, R., and J. L. Scott. 1968. Leukocyte labeling with51chromium. I. Technic and results in normal subjects. Blood 32: 738–754.
MacLennan, I. C. M., and G. Loewi. 1968. The effect of peripheral lymphocytes from patients with inflammatory joint disease on human target cellsin vitro. Clin. Exp. Immunol. 3: 385–391.
Holm, G., and P. Perlmann. 1967. Quantitative studies on phytohaemagglutinin-induced cytotoxicity by human lymphocytes against homologous cells in tissue culture. Immunology 12: 525–536.
Sanderson, A. R. 1964. Cytotoxic reactions of mouse iso-antisera: Preliminary considerations. Br. J. Exp. Pathol. 45: 398–408.
DeBernardo, E., G. Claus, and I. Krisko. 1977. The spontaneous release of51Cr from labeled EL-4 lymphoma cells as dependent upon the composition of the cell population. Exp. Cell Biol. 45: 122–140.
Sanderson, C. J. 1976. The uptake and retention of chromium by cells. Transplantation 21: 526–529.
Ronai, P. M. 1969. The elution of51Cr from labelled leukocytes—a new theory. Blood 33: 408–413.
Rajam, P. C., and A.-L. Jackson. 1958. Distribution and valence state of radiochromium in intracellularly labeled Ehrlich mouse ascites carcinoma cells. Proc. Soc. Exp. Biol. Med. 99: 210–213.
Skrabut, E. M., N. Catsimpoolas, J. P. Crowley, and C. R. Valeri. 1976. [51Cr] Sodium chromate incorporation into the soluble protein fraction of the human erythrocyte: Binding not associated with the haemoglobin monomeric subunit. Biochem. Biophys. Res. Commun. 69: 672–677.
Scaife, J. F., and P. V. Vittorio. 1964. The use of chromium-51 as a sensitive quantitative criterion of early radiation damage to rat thymocytes. Can. J. Biochem. 42: 503–512.
Pearson, H. A. 1963. The binding of Cr51 to hemoglobin. I.In vitro studies. Blood 22: 218–230.
Bainbridge, D. R., L. Brent, and G. Gowland. 1966. Distribution of allogeneic51Cr-labelled lymph node cells in mice. Transplantation 4: 138–153.
Bunting, W. L., J. M. Kiely, and C. A. Owen, Jr. 1963. Radiochromium-labeled lymphocytes in the rat. Proc. Soc. Exp. Biol. Med. 113: 370–374.
Gibaldi, M., and D. Perrier. 1975.Pharmacokinetics. Marcel Dekker, Inc., New York, pp. 281–292.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Zawydiwski, R., Duncan, G.R. Spontaneous51Cr release by isolated rat hepatocytes: An indicator of membrane damage. In Vitro 14, 707–714 (1978). https://doi.org/10.1007/BF02616167
Issue Date:
DOI: https://doi.org/10.1007/BF02616167